Skip to main content
Top

25-04-2013 | Case Report

A case of Degos disease: demonstration of C5b-9-mediated vascular injury

Authors: Masayu Umemura, Yusuke Miwa, Ryo Yanai, Sakiko Isojima, Takahiro Tokunaga, Hiroyuki Tsukamoto, Ryo Takahashi, Nobuyuki Yajima, Tsuyoshi Kasama, Nanako Takahashi, Hirohiko Sueki, Sayaka Yamaguchi, Katsuhito Arai, Yoshiaki Takeuchi, Nobuyuki Ohike, Tomoko Norose, Toshiko Yamochi-Onizuka, Masafumi Takimoto

Published in: Modern Rheumatology

Login to get access

Abstract

A 68-year-old Japanese male presented with atrophic erythematous white lesions with peripheral dark reddish rims on his back. Multiple ulcers were detected from his stomach to his large intestine using endoscopy. Although the patient was given high doses of a steroid, aspirin, dipyridamole, and intravenous immunoglobulin therapy, he died of gastrointestinal hemorrhage, perforation and septic shock. An autopsy examination revealed pauci-inflammatory thrombotic microangiopathy with endothelial cell injury, fibrous occlusive arteriopathy, and vascular C5b-9 deposition in the wall of the gastrointestinal tract from the esophagus to the large intestine as well as in the dermis of the skin.
Literature
1.
go back to reference Beljaards RC, Starink TM, Meuwissen SG. 2 families with malignant atrophic papulosis (Degos disease) (in Dutch). Ned Tijdschr Geneeskd. 1988;132:269–71.PubMed Beljaards RC, Starink TM, Meuwissen SG. 2 families with malignant atrophic papulosis (Degos disease) (in Dutch). Ned Tijdschr Geneeskd. 1988;132:269–71.PubMed
2.
go back to reference Durie BG, Stroud JD, Kahn JA. Progressive systemic sclerosis with malignant atrophic papulosis. Arch Dermatol. 1969;100:575–81.PubMedCrossRef Durie BG, Stroud JD, Kahn JA. Progressive systemic sclerosis with malignant atrophic papulosis. Arch Dermatol. 1969;100:575–81.PubMedCrossRef
3.
go back to reference Fernandez-Flores A, Manjon JA, Mencia J. Diabetes mellitus and Degos disease (published correction appears in Bratisl Lek Listy. 2008;109:533). Bratisl Lek Listy. 2008;109:414–7.PubMed Fernandez-Flores A, Manjon JA, Mencia J. Diabetes mellitus and Degos disease (published correction appears in Bratisl Lek Listy. 2008;109:533). Bratisl Lek Listy. 2008;109:414–7.PubMed
4.
go back to reference Snow JL, Muller SA. Degos syndrome: malignant atrophic papulosis. Semin Dermatol. 1995;14:99–105.PubMedCrossRef Snow JL, Muller SA. Degos syndrome: malignant atrophic papulosis. Semin Dermatol. 1995;14:99–105.PubMedCrossRef
5.
go back to reference Doutre MS, Beylot C, Bioulac P, et al. Skin lesions resembling malignant atrophic papulosis in lupus erythematosus. Dermatologica. 1987;175:45–6.PubMedCrossRef Doutre MS, Beylot C, Bioulac P, et al. Skin lesions resembling malignant atrophic papulosis in lupus erythematosus. Dermatologica. 1987;175:45–6.PubMedCrossRef
6.
go back to reference Notash AY, Mazoochy H, Mirshams M, et al. Lethal systemic Degos disease with prominent cardio-pulmonary involvement. Saudi Med J. 2008;29:133–7.PubMed Notash AY, Mazoochy H, Mirshams M, et al. Lethal systemic Degos disease with prominent cardio-pulmonary involvement. Saudi Med J. 2008;29:133–7.PubMed
7.
go back to reference High WA, Aranda J, Patel SB, et al. Is Degos’ disease a clinical and histological end point rather than a specific disease? J Am Acad Dermatol. 2004;50:895–9.PubMedCrossRef High WA, Aranda J, Patel SB, et al. Is Degos’ disease a clinical and histological end point rather than a specific disease? J Am Acad Dermatol. 2004;50:895–9.PubMedCrossRef
8.
go back to reference Megro CM, Poe JC, Kim C et al. Degos disease: a C5b-9/interferon-α-mediated endotheliopathy syndrome. Am J Clin Pathol. 2011;135:599–610. Megro CM, Poe JC, Kim C et al. Degos disease: a C5b-9/interferon-α-mediated endotheliopathy syndrome. Am J Clin Pathol. 2011;135:599–610.
9.
go back to reference Tsao H, Busam K, Barnhill RL, et al. Lesions resembling malignant atrophic papulosis in a patient with dermatomyositis. J Am Acad Dermatol. 1997;36:317–9.PubMedCrossRef Tsao H, Busam K, Barnhill RL, et al. Lesions resembling malignant atrophic papulosis in a patient with dermatomyositis. J Am Acad Dermatol. 1997;36:317–9.PubMedCrossRef
10.
go back to reference Heymann WR. Degos disease: considerations for reclassification. J Am Acad Dermatol. 2009;61(3):505–06. Heymann WR. Degos disease: considerations for reclassification. J Am Acad Dermatol. 2009;61(3):505–06.
11.
go back to reference Kolb WP, Muller-Eberhard HJ. Neoantigens of the membrane attack complex of complement. Proc Natl Acad Sci USA. 1975;72:1687–9.PubMedCrossRef Kolb WP, Muller-Eberhard HJ. Neoantigens of the membrane attack complex of complement. Proc Natl Acad Sci USA. 1975;72:1687–9.PubMedCrossRef
12.
go back to reference Kinoshita T. Biology of complement: the overture. Immunol Today. 1991;12:202–5.CrossRef Kinoshita T. Biology of complement: the overture. Immunol Today. 1991;12:202–5.CrossRef
13.
go back to reference Norris DA, Lee LA. Antibody-dependent cellular cytotoxicity and skin disease. J Invest Dermatol. 1985;85(1 suppl):165S–75S.PubMedCrossRef Norris DA, Lee LA. Antibody-dependent cellular cytotoxicity and skin disease. J Invest Dermatol. 1985;85(1 suppl):165S–75S.PubMedCrossRef
14.
go back to reference Norris DA, Ryan SB, Kissinger RM, Fritz KA, Boyce ST. Systematic comparison of antibody-mediated mechanisms of keratinocyte lysis in vitro. J Immunol. 1985;135:1073–9.PubMed Norris DA, Ryan SB, Kissinger RM, Fritz KA, Boyce ST. Systematic comparison of antibody-mediated mechanisms of keratinocyte lysis in vitro. J Immunol. 1985;135:1073–9.PubMed
15.
go back to reference Norris DA. Pathomechanisms of photosensitive lupus erythematosus. J Invest Dermatol. 1993;100:58S–68S.PubMedCrossRef Norris DA. Pathomechanisms of photosensitive lupus erythematosus. J Invest Dermatol. 1993;100:58S–68S.PubMedCrossRef
Metadata
Title
A case of Degos disease: demonstration of C5b-9-mediated vascular injury
Authors
Masayu Umemura
Yusuke Miwa
Ryo Yanai
Sakiko Isojima
Takahiro Tokunaga
Hiroyuki Tsukamoto
Ryo Takahashi
Nobuyuki Yajima
Tsuyoshi Kasama
Nanako Takahashi
Hirohiko Sueki
Sayaka Yamaguchi
Katsuhito Arai
Yoshiaki Takeuchi
Nobuyuki Ohike
Tomoko Norose
Toshiko Yamochi-Onizuka
Masafumi Takimoto
Publication date
25-04-2013
Publisher
Springer Japan
Published in
Modern Rheumatology
Print ISSN: 1439-7595
Electronic ISSN: 1439-7609
DOI
https://doi.org/10.1007/s10165-013-0888-x
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.